Examining the Adoption of Drug-Eluting Stents

Below are the available bulk discount rates for each individual item when you purchase a certain amount

Register as a Premium Educator at hbsp.harvard.edu, plan a course, and save your students up to 50% with your academic discount.

Publication Date:
September 25, 2008

Source:
Harvard Business School

Marketers are often tasked with exploring the factors that impact the long-run adoption of a new product or technology. The new product under consideration here is the drug-eluting stent: a device which props open a clogged artery to the heart and then releases medication that reduces the risk of artery re-blockage. In light of recent medical and competitive trends in the market, the case prompts students to examine the future adoption of drug-eluting stents as well as to consider the potential marketing actions to be taken by Medtronic for ENDEAVOR – a newly approved stent that will hit the market in 2008.

Copyright © 2021 Harvard Business School Publishing. All rights reserved. Harvard Business Publishing is an affiliate of Harvard Business School.

Examining the Adoption of Drug-Eluting Stents

Research & References of Examining the Adoption of Drug-Eluting Stents|A&C Accounting And Tax Services
Source

error: Content is protected !!